| HS Code | 657284 |
| Chemical Name | 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde |
| Molecular Formula | C20H14FNO |
| Appearance | solid |
| Smiles | O=Cc1c2ccnc(C3CC3)c2cc(c1)-c4ccc(F)cc4 |
| Inchi | InChI=1S/C20H14FNO/c21-17-9-7-15(8-10-17)18-11-12-22-20(14-18)19(13-23)16-5-3-4-6-16/h3-12,14H,13H2 |
| Storage Conditions | Store in a cool, dry place, away from light |
| Synonyms | No common synonyms |
| Purity | Varies; specified by supplier |
As an accredited 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass vial containing 5 grams of 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde, securely sealed with a screw cap. |
| Container Loading (20′ FCL) | Container loading (20′ FCL): Securely packed 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde in sealed drums, with appropriate labeling and documentation. |
| Shipping | This product, 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde, ships in secure, chemical-resistant packaging to prevent leaks and contamination. It is handled according to all relevant safety regulations, with full documentation. Temperature and moisture conditions are controlled as necessary. Delivery is via licensed carriers, and only to qualified institutions or authorized recipients. |
| Storage | Store **2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde** in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Keep away from incompatible materials such as strong oxidizers and acids. Refrigeration (2–8°C) is recommended to maintain stability. Label container clearly and follow standard chemical safety protocols during handling and storage. |
| Shelf Life | Shelf life of 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde is typically 2 years when stored cool, dry, protected from light. |
As the manufacturer of 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde, we focus exclusively on its established, high-value downstream applications in advanced industries. The following sections highlight targeted, real-world integration in pharmaceutical intermediates for oncology, research active pharmaceutical ingredient (API) synthesis, specialty agrochemical synthesis, and high-purity reference standard preparation. For each field, we specify industry benchmarks, actual formulation practices, downstream processing steps, and the range of finished goods produced by our direct clients.
Pharmaceutical manufacturers incorporate this quinoline compound as a key aldehyde intermediate for developing anti-cancer small molecule drugs, particularly in quinoline-derived kinase inhibitor projects. Compliance with ICH Q7 and current GMP mandates strict traceability, stability data, and impurity profiling from the raw material stage. Oncologic API syntheses typically employ a stepwise functionalization route, introducing the quinoline aldehyde at the heteroarylation or condensation step where it controls the final ring orientation and influences yield purity. Downstream units use in-situ monitoring and batch release protocols to ensure batch-to-batch reproducibility before progressing to API isolation and purification.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
This material supports research and pilot-scale synthesis of quinoline-based lead molecules for advanced medicinal chemistry programs. Originating from direct procurement for high-throughput library construction, it meets the analytical characterization and reproducibility standards required in non-GMP/preclinical environments. Formulation chemists adjust aldehyde addition based on structure-activity readouts and scale requirements. Researchers integrate it post-halogenation or aryl-fluorination, often using microreactor and parallel synthesis platforms, with real-time NMR and purity analysis supporting combinatorial development.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Agrochemical producers use this building block for synthesizing herbicidal and fungicidal active ingredients, particularly those with fluorinated quinoline frameworks. Raw material conformity must comply with national pesticide ingredient registration and trace metal/organic impurity limits specified by end-market legislation (e.g., EPA in the US, GB/T in China). The material enters at the nucleophilic substitution or condensation step, guiding product selectivity in the final agrochemical scaffold. Manufacturer QC tailors the ratio based on active ingredient concentration and downstream formulation (wettable powder, granule, or EC).
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Analytical labs and pharmaceutical QC departments source this compound for generating certified reference standards needed for LC-MS, HPLC, and GC validation, specifically in monitoring quinoline-derived drugs. Purity specifications comply with international pharmacopoeias and ISO reference material regulations. Technicians introduce the substance post-synthesis during recrystallization and isotopic labeling processes. In these workflows, precise weighing and high-solvent compatibility are crucial for producing standards with traceable certificate of analysis attached. Batch records capture both source and downstream value chain traceability.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Competitive 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8618005193850
Email: sales8@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
In years of synthesizing complex quinoline derivatives, the molecule 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde has become familiar in our workshops. As a manufacturer, we measure value by more than a product’s purity label—we see it in how the product performs in downstream synthesis and how its reproducibility makes or breaks an entire project. We learned that not all aldehydes with similar backbone or nominal grade behave in the same way when scaled beyond a few grams. This particular quinoline carbaldehyde is a good example: its dual substituents on the core ring make it stand out in advanced pharmaceutical, agrochemical, and material science applications where precision matters.
Our product is produced in kilogram quantities with an assay checked by both HPLC and NMR. Commercial users often ask about single-digit impurity management, since even side-products at half a percent can derail yield or introduce unknowns into advanced synthesis. Each batch undergoes crystallization steps that we’ve optimized through extensive trial: the choice of solvent, temperature graduation, and anti-solvent mechanics have direct impact on both morphology and downstream filtration.
Moisture management remains vitalbecause imine formation during condensation steps occurs rapidly if trace water persists. We dry the material under high-vacuum overnight and package with inert gas, not just for shelf life, but for actual handling safety at the customer’s bench.
Unlike basic quinoline-3-carbaldehyde, the cyclopropyl and para-fluorophenyl groups together provide increased molecular rigidity and a distinct electronic influence. Chemists looking to build complex heterocycles or attempt late-stage modifications, including palladium-catalyzed couplings, lean into these features to escort reactivity down a narrower, more predictable path. We regularly see feedback that the cyclopropyl moiety resists undesired ring-opening in transition-metal catalyzed steps, which can reduce troubleshooting time for scale-ups.
Fluorination changes both reactivity and physical behavior: the 4-fluorophenyl motif tweaks polarity, handling, and (more subtly) interaction with potential biological targets. This change shows up in higher performance during the synthesis of fluorinated analogs of known actives, as well as enhanced stability against oxidative degradation under ambient conditions—a feature particularly requested by contract developers concerned about shipment or bench life.
We offer a standardized kilo-scale model, typically crystallized as pale yellow needles. Every analytical run checks for a minimum HPLC purity of 99 percent, with specific attention to the cyclopropyl ring’s integrity. Our NMR fingerprinting picks up any minor byproduct, especially oxidized or reduced versions of the parent scaffold, which we have learned to suppress in both the Grignard insertion and quinoline core construction.
Glassware, air control in drying, and direct observation during batch finishing aren’t just formalities: they underpin the batch-to-batch reliability that researchers depend on. We handle strict packaging—double-sealed barriers, nitrogen filled containers, and opaque storage—to limit photooxidative or hydrolytic change, especially during long transits.
Researchers adopt this carbaldehyde for synthesis of kinases inhibitors, advanced light-absorbing materials, or multi-fused ring systems. Improved solubility profile, gained from the cyclopropyl and fluoro substitutions, plays out during both low-temperature spirit-based extractions and high-temperature cyclization. One frequent application is as a core scaffold in combinatorial chemistry libraries for small molecule discovery: with two sites ready for modification, the core structure serves as a springboard for SAR (structure-activity relationship) investigations.
In our own pilot lab, the aldehyde group survives cross-coupling conditions that degrade similar ring systems. Over the years, comparative batch stability testing at elevated humidity and under continuous light has shown that our purification methods matter more than choice of basic feedstock. Clean handling and solid analytical data—confirmed right in-house—give users more confidence for regulatory submissions, especially when the downstream compound heads for preclinical investigation.
Producing this quinoline carbaldehyde has never followed a single recipe. Each scale-up run exposes subtle differences in heat transfer, pH control, and reactant loading. We improved isolation yields by reformulating our oxidation approach, switching to a mild, buffered system. This adjustment reduced formation of colored byproducts, which aren’t always harmful but complicate post-purification color testing and can interfere with photometric assays.
Many who order from us specifically pursue robust intermediates—they value stability and reproducibility more than theoretical maximum yield. That has guided our approach: For instance, by adopting a two-step crystallization, we generate a purer batch, even at the cost of slight yield reduction. Reproducibility is easier to manage and the end product retains physical consistency for users in GMP (Good Manufacturing Practice) settings.
A look at the wider market reveals numerous close relatives: base 4-(4-fluorophenyl)quinoline-3-carbaldehyde and unsubstituted quinoline aldehydes often have more literature precedent, but the addition of the cyclopropyl group changes the game. This is not a block addition—it influences ring puckering, reactivity in hot solvent conditions, and mechanistic stability during oxidation or reduction.
Some clients arrive with experiences using only basic quinoline cores and express surprise at the resilience of the cyclopropyl-modified version. The product retains integrity under Pd or Cu catalysis, with side reactions suppressed. This allows more adventurous transformations further downstream, where lesser molecules might falter and generate mysterious byproducts or trace volatility.
Our analytical runs consistently find that trace impurities in products from shortcut syntheses (such as one-pot oxidations with unchecked byproduct formation) persist and become a headache for analytical chemists. Our tailored double-crystallization steps and fixed reaction parameters reduce variability and are reflected in improved LOD (limit of detection) in third-party verification.
Chemists looking to streamline complex, iterative syntheses gain more value from stability and purity than from any marginal price difference. Our internal data, pooled from dozens of research partners, show higher completion rates during advanced heterocycle assembly when batches originate from high-purity, rigorously purified 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde. Most failures from competitors’ materials trace back to latent phase impurities—sometimes invisible in a standard certificate of analysis, but strongly impacting difficult transformations such as cross-couplings or Friedel-Crafts acylation.
Our collaboration with custom synthesis teams underlines another point: robust aldehyde intermediates speed up troubleshooting, save time on re-purification, and open up options for parallel modification of the aromatic or side chain moieties.
Through our direct manufacturing experience, we have seen clear benefits in full traceability from raw material to finished kilogram. Our approach never relegates batch waste to guesswork; waste streams undergo detailed imaging and analytical review before disposal. As regulatory oversight grows worldwide, trace metal content, residual solvents, and unusual side products receive even closer inspection. While many labs accept “research only” compounds from unknown sources, those with analytical and safety responsibilities increasingly demand cleaner, well-sourced materials.
This chemical’s fluorinated motif triggers even more regulatory questions, especially for pharmaceutical and crop science developers. Over our production history, we have reduced residual polar solvent contamination to parts-per-million levels, and our batches consistently meet advanced analytical thresholds for EU and North American compliance audits.
No system remains perfect. We still work on cutting solvent usage, shortening cycle times for oxidation steps, and improving overall yield in line with customers’ environmental and cost pressures. A recent team optimization cut filtration time nearly by half; we invest those hours in tighter analytical review, ensuring fewer complaints and returns.
We also recognize persistent challenges in maintaining aldehyde purity during hot summer months or long-distance transit. Cold chain shipping solutions have proven essential, especially for deliveries to tropical locations where heat spikes above 30 degrees threaten batch stability.
Scientific progress depends on the quality of starting materials. Many intermediates work in controlled demo runs but break down in unpredictable ways when scale or extreme conditions enter the picture. Years of overseeing manufacturing lines have reinforced that consistency and rigorous testing pay off for those performing challenging transformations.
Our reputation stands on reliability, not just for the purified quinoline product but for insight into pitfalls during its use. Troubles often appear as unexplained drops in yield or failed downstream reactions, and they usually trace to undetected contaminants or minor degradation during shipment or storage. Our focus on tightly controlled synthesis and responsive, detailed documentation helps users sidestep these stumbling blocks.
We regularly field questions from researchers working on time-sensitive deliverables, or those scaling up for regulatory testing. Sometimes issues pop up with solubility in non-standard solvents or with failed attempts to derivatize the aldehyde during library creation. Fast, honest discussion rooted in direct production experience—rather than distributor guesswork—lets us problem-solve more efficiently. We keep updated data on stability, solubility trends, and impurity fate, and feed those lessons back into our process.
A great many chemical vendors operate outside the realities of full-scale synthesis: brokered samples lose value when the origin and handling remain unclear. Our users return again and again because direct-from-source means less ambiguity, greater consistency, and a channel for technical support grounded in real production. This cycle—transparent conversation, results-driven feedback, real-world adaptation—sustains not just our business, but each collaborator’s research momentum.
Many of the latest targets in both medicinal and material science development call for ever-more specialized building blocks. Direct partners continue to ask for higher homogeneity, fewer residuals, and tighter analytical reporting. We committed to regular instrument upgrades and periodic process redesign, knowing that the market’s technical standards are rising.
Efforts underway at our site include green chemistry initiatives—slashing hazardous reagents, aiming for solvent recovery, and realigning batch processing to minimize energy use. While the underlying quinoline-3-carbaldehyde chemistry remains robust, synthesis can always be safer, faster, and cleaner.
Each time we pilot a new process or rerun classic optimization—say, to further dry the product or to switch to less hazardous oxidants—we do so not just to tick a compliance box, but to bolster real-world reliability for those pushing the boundaries of organic synthesis.
Through each run, from the smallest R&D scale to shipping full kilogram lots, our team observes the subtleties inherent in making 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde. Close monitoring, hands-on troubleshooting, and adaptation in real time shape a product that does more than just meet a specification. Years of firsthand engagement with synthesis—adjusting for exotherm, tweaking solvent ratios, catching when a separation step needs patience—feed back into each batch, making sure those who build with our intermediates enjoy fewer surprises.
Customers working at the leading edge—whether in drug candidates, photonic polymers, or specialty ligands—share shaped insight with us, forming a technical dialogue that sharpens our focus. We gain as much from user feedback as from the spectrometers in our own lab. Every bit of this lived experience ultimately reinforces the difference between a commodity item and a purpose-built synthesis product. No distributor, no broker, can substitute for this cumulative know-how shared between bench and reactor.